Skip to content
10-Q

Quarterly Report

CORE LABORATORIES INC. CLB

0000950170-24-117122

← back to feed
Filed
Oct 24, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2024 · Oct 18, 2024 46.95M sh
Long Term Debt Q3 2024 · Sep 30, 2024 $139.87M
Long Term Debt Q3 2024 · Dec 31, 2023 $163.13M
Cash And Equivalents Q3 2024 · Sep 30, 2024 $21.47M
Cash And Equivalents Q3 2024 · Dec 31, 2023 $15.12M
Stockholders Equity Q3 2024 · Sep 30, 2024 $250.74M
Stockholders Equity Q3 2024 · Dec 31, 2023 $224.82M
Current Liabilities Q3 2024 · Sep 30, 2024 $94.94M
Current Liabilities Q3 2024 · Dec 31, 2023 $88.1M
Current Assets Q3 2024 · Sep 30, 2024 $235.23M
Current Assets Q3 2024 · Dec 31, 2023 $223.14M
Total Assets Q3 2024 · Dec 31, 2023 $586.4M
Total Assets Q3 2024 · Sep 30, 2023 $592.41M
Shares Diluted Q3 2024 · Sep 30, 2023 47.6M sh
Shares Diluted Q3 2024 · Sep 30, 2023 47.54M sh
Stock Repurchased Q3 2024 · Sep 30, 2023 $418K
Dividends Paid Q3 2024 · Sep 30, 2023 $1.4M
Capex Q3 2024 · Sep 30, 2023 $7.84M
Operating Cash Flow Q3 2024 · Sep 30, 2023 $5.36M
Eps Diluted Q3 2024 · Sep 30, 2023 $0.19
Eps Diluted Q3 2024 · Sep 30, 2023 $0.73
Eps Basic Q3 2024 · Sep 30, 2023 $0.20
Eps Basic Q3 2024 · Sep 30, 2023 $0.74
Net Income Q3 2024 · Sep 30, 2023 $9.26M
Net Income Q3 2024 · Sep 30, 2023 $34.48M
Operating Income Q3 2024 · Sep 30, 2023 $14.67M
Operating Income Q3 2024 · Sep 30, 2023 $40.06M
Revenue Q3 2024 · Sep 30, 2023 $125.34M
Revenue Q3 2024 · Sep 30, 2023 $381.58M